Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001209191-22-040603

Director acquired 1,372 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Dubin Glenn Director 2022-07-01 Grant or award +1,372 $8.03 $11,017 2,245 D
Loading xslF345X03/doc4.xml…